Bios Clinical Opportunity Fund, LP - Insider Trading & Ownership

Location
1751 River Run, Suite 400, Fort Worth, TX
Summary
The estimated value of insider holdings of Bios Clinical Opportunity Fund, LP is at least $1.74M dollars as of August 12, 2024. Bios Clinical Opportunity Fund, LP is the 10%+ Owner of ACTUATE THERAPEUTICS, INC. and owns shares of ACTUATE THERAPEUTICS, INC. (ACTU) stock worth about $1.22M. Bios Clinical Opportunity Fund, LP is the Director, 10%+ Owner of COGNITION THERAPEUTICS INC and owns shares of COGNITION THERAPEUTICS INC (CGTX) stock worth about $525K.
Signature
Bios Clinical Opportunity Fund, LP By: Bios Equity COF, LP, its general partner By: Bios Capital Management, LP, its general partner By: Bios Advisors, LLC, its general partner By: /s/ Aaron Glenn Louis Fletcher, Manager
All Insider Reports
All Insider Reports

Ownership of Bios Clinical Opportunity Fund, LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACTU ACTUATE THERAPEUTICS, INC. 10%+ Owner $1.22M Aug 12, 2024
CGTX COGNITION THERAPEUTICS INC Director, 10%+ Owner $525K Nov 8, 2023
INAB IN8BIO, INC. 10%+ Owner Dec 13, 2023

There are no insider transactions reported by Bios Clinical Opportunity Fund, LP